United States biotech firm Moderna on Wednesday said it was pursuing regulatory approval for its Covid vaccine in children aged six months to six years after the two-shot regimen was found to be safe and produced a strong immune response.from World News Headlines, Latest International News, World Breaking News - Times of India
No comments:
Post a Comment